Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translating Music to Touch: Exploring Tactile Perception of Pitch, Roughness, and Pleasantness.

IEEE transactions on haptics·2026
Same author

Modern management of congenital thrombotic thrombocytopenic purpura (cTTP).

Hematology. American Society of Hematology. Education Program·2025
Same author

Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial.

BMJ open·2025
Same author

Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.

Blood·2025
Same author

Exploring the Use of Sea Swimming as an Intervention With Young People With Mental Health Challenges: A Qualitative Descriptive Study.

International journal of mental health nursing·2025
Same author

The effects of maternal flow on placental diffusion-weighted MRI and intravoxel incoherent motion parameters.

Magnetic resonance in medicine·2024

Related Experiment Video

Updated: Jun 22, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Vascular dysfunction in the diabetic placenta: causes and consequences.

Lopa Leach1, Alice Taylor, Flavia Sciota

  • 1School of Biomedical Sciences, Centre for Integrated Systems Biology and Medicine, Institute of Clinical Research, Faculty of Medicine and Health Sciences, University of Nottingham, UK. lopa.leach@nottingham.ac.uk

Journal of Anatomy
|July 1, 2009
PubMed
Summary

Maternal diabetes impacts the human placenta's vascular system, causing increased blood vessel growth and leakiness. Further research is needed to determine if high maternal blood sugar or fetal insulin is the primary cause.

More Related Videos

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

Related Experiment Videos

Last Updated: Jun 22, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

Area of Science:

  • Obstetrics and Gynecology
  • Vascular Biology
  • Endocrinology

Background:

  • The fetoplacental vascular system is susceptible to maternal diabetes.
  • Diabetic conditions can lead to fetal endocrine issues, affecting placental vasculature.
  • Existing research describes placental vascular changes in Type 1 diabetes, including increased angiogenesis and leakiness.

Purpose of the Study:

  • To investigate the vascular changes in the human placenta due to maternal diabetes.
  • To explore the roles of maternal hyperglycemia and fetal hyperinsulinemia in these vascular alterations.
  • To elucidate the molecular mechanisms underlying placental vascular pathology in diabetes.

Main Methods:

  • Analysis of placental vascular phenotypes in Type 1 diabetic pregnancies.
  • Review of mechanistic studies on high glucose and insulin effects on vascular systems.
  • Discussion of the roles of advanced glycation products and oxidative stress.

Main Results:

  • Diabetic placentas exhibit increased angiogenesis, altered vessel maturity, and enhanced leakiness.
  • Elevated placental vascular endothelial growth factor (VEGF) is associated with these vascular changes.
  • Mechanistic studies indicate high glucose and insulin affect vascular endothelial growth factor, nitric oxide, and protein kinase C, impacting vascular junctions and albumin leakage.

Conclusions:

  • Maternal diabetes induces significant vascular changes in the human placenta.
  • The precise contribution of maternal hyperglycemia versus fetal hyperinsulinemia requires further investigation in human placentas.
  • Altered molecular pathways involving VEGF, nitric oxide, protein kinase C, and advanced glycation products contribute to diabetic placental vascular pathology.